Ovbiagele B., Goldstein L. B., Amarenco P., Messig M., Sillesen H., Callahan A., Hennerici M. G., Zivin J., Welch K. M. A.. Prediction of major vascular events after stroke: The stroke prevention by aggressive reduction in cholesterol levels trial. Journal of Stroke and Cerebrovascular Diseases 2014; 23 (4):778-784. doi:
10.1016/j.jstrokecerebrovasdis.2013.12.001
Ovbiagele B., Reeves M. J., Nasiri M., Johnston S. C., Bath P. M., Saposnik G.. A simple risk index and thrombolytic treatment response in acute ischemic stroke. JAMA Neurology 2014; 71 (7):848-854. doi:
10.1001/jamaneurol.2014.689
Ovbiagele B., Reeves M. J., Nasiri M., Johnston S. C., Bath P. M., Saposnik G.. A simple risk index and thrombolytic treatment response in acute ischemic stroke. JAMA Neurol 2014; 71 (7):848-54. doi:
10.1001/jamaneurol.2014.689
Ovbiagele B., Saposnik G.. Risk index and thrombolytic treatment in acute ischemic stroke-reply. JAMA Neurol 2014; 71 (10):1326. doi:
10.1001/jamaneurol.2014.2297
Ovbiagele B., Saposnik G.. Risk Index and Thrombolytic Treatment in Acute Ischemic Stroke Reply. JAMA Neurology 2014; 71 (10):1326-1326.
Ovbiagele B., Schwamm L. H., Smith E. E., Grau-Sepulveda M. V., Saver J. L., Bhatt D. L., Hernandez A. F., Peterson E. D., Fonarow G. C.. Patterns of care quality and prognosis among hospitalized ischemic stroke patients with chronic kidney disease. J Am Heart Assoc 2014; 3 (3):. doi:
10.1161/jaha.114.000905
Ovbiagele B., Schwamm L. H., Smith E. E., Grau-Sepulveda M. V., Saver J. L., Bhatt D. L., Hernandez A. F., Peterson E. D., Fonarow G. C.. Hospitalized Hemorrhagic Stroke Patients with Renal Insufficiency: Clinical Characteristics, Care Patterns, and Outcomes. Journal of Stroke and Cerebrovascular Diseases 2014; 23 (9):2265-2273.
Ovbiagele B., Smith E. E., Schwamm L. H., Grau-Sepulveda M. V., Saver J. L., Bhatt D. L., Hernandez A. F., Peterson E. D., Fonarow G. C.. Chronic Kidney Disease and Bleeding Complications After Intravenous Thrombolytic Therapy for Acute Ischemic Stroke. Circulation-Cardiovascular Quality and Outcomes 2014; 7 (6):929-935.
Ovbiagele B., Smith E. E., Schwamm L. H., Grau-Sepulveda M. V., Saver J. L., Bhatt D. L., Hernandez A. F., Peterson E. D., Fonarow G. C.. Chronic kidney disease and bleeding complications after intravenous thrombolytic therapy for acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2014; 7 (6):929-35. doi:
10.1161/circoutcomes.114.001144
Owolabi M. O., Akinyemi R. O., Gebregziabher M., Olaniyan O., Salako B. L., Arulogun O., Ovbiagele B.. Randomized controlled trial of a multipronged intervention to improve blood pressure control among stroke survivors in Nigeria. International Journal of Stroke 2014; 9 (8):1109-1116.
Owolabi M. O., Akinyemi R. O., Hurst S., Arulogun O., Olaniyan O., Gebregziabher M., Salako B. L., Ovbiagele B.. Tailored Hospital-based Risk Reduction to Impede Vascular Events After Stroke (THRIVES) Study: Qualitative Phase Protocol. Crit Pathw Cardiol 2014; 13 (1):29-35. doi:
10.1097/hpc.0000000000000005
Owolabi M. O., Akinyemi R. O., Hurst S., Arulogun O., Olaniyan O., Gebregziabher M., Salako B. L., Ovbiagele B.. Tailored hospital-based risk reduction to impede vascular events after stroke (THRIVES) Study: Qualitative phase protocol. Critical Pathways in Cardiology 2014; 13 (1):29-35. doi:
10.1097/HPC.0000000000000005
Owolabi M. O., Mensah G. A., Kimmel P. L., Adu D., Ramsay M., Waddy S. P., Ovbiagele B., Rabadan-Diehl C., Rasooly R., Akarolo-Anthony S. N., Rotimi C.. Understanding the rise in cardiovascular diseases in Africa: Harmonising H3Africa genomic epidemiological teams and tools. Cardiovascular Journal of Africa 2014; 25 (3):134-136. doi:
10.5830/CVJA-2014-030
Owolabi M. O., Ovbiagele B.. Global clinical neuroscience: Journey of a thousand miles begins with a single step. Journal of the Neurological Sciences 2014; 344 (1-2):223-223.
Oyer S. L., Fritsch V. A., Lentsch E. J.. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients. Annals of Otology Rhinology & Laryngology 2014; 123 (2):94-100. doi:
10.1177/0003489414523563
Oyer S. L., Fritsch V. A., Lentsch E. J.. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients. Annals of Otology, Rhinology and Laryngology 2014; 123 (2):94-100. doi:
10.1177/0003489414523563
Ozark S. D., Jauch E. C.. Putting it all together for best stroke practice, all the time. Stroke 2014; 45 (5):1243-4. doi:
10.1161/strokeaha.114.005090
Ozark S., Goodman D., Holmstedt C.. Stroke. In: Ovbiagele B., editor. Best Practices in Neurological Care. : , 2014. p. 145-167. doi:
10.2217/EBO.13.485
Pachaiyappan B., Woster P. M.. Design of small molecule epigenetic modulators. Bioorganic and Medicinal Chemistry 2014; 24 (1):21-32.
Pachaiyappan Boobalan, Wang Bo, Zhang Yong-Mei, Woster Patrick M.. Discovery of a novel class of potent, broad-spectrum antibacterial agents containing bis-thioureas and bis-ureas. Abstracts of Papers, 248th ACS National Meeting and Exposition, San Francisco, CA, United States, August 10-14, 2014 2014; 2014 (Aug 10-14):MEDI-311.
Paintlia M. K., Singh I., Singh A. K.. Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease. Journal of Neuroscience Research 2014; 93 (1):28-42. doi:
10.1002/jnr.23476
Palanisamy A. P., Cheng G., Sutter A. G., Evans Z. P., Polito C. C., Jin L., Liu J., Schmidt M. G., Chavin K. D.. Mitochondrial uncoupling protein 2 induces cell cycle arrest and necrotic cell death. Metab. Syndr. Relat. Disord. 2014; 12 (2):132-142. doi:
10.1089/met.2013.0096
Palanisamy A. P., Cheng G., Sutter A. G., Liu J., Lewin D. N., Chao J., Chavin K.. Adenovirus-mediated eNOS expression augments liver injury after ischemia/reperfusion in mice. PLoS One 2014; 9 (3):e93304. doi:
10.1371/journal.pone.0093304
Palanisamy A., Sutter A., Chavin K.. Knocking Out TLR4 Protects Mice From Non Alcoholic SteatoHepatitis But Not Obesity. American Journal of Transplantation 2014; 14 ():296-296.
Palanisamy A., Sutter A., Chavin K.. Knocking Out TLR4 Protects Mice From Non Alcoholic SteatoHepatitis But Not Obesity. Transplantation 2014; 98 ():296-296.
Palanisamy Arun P., Cheng Gang, Sutter Alton G., Evans Zachary P., Polito Carmen C., Jin Lan, Liu John, Schmidt Michael G., Chavin Kenneth D.. Mitochondrial Uncoupling Protein 2 Induces Cell Cycle Arrest and Necrotic Cell Death. Metab. Syndr. Relat. Disord. 2014; 12 (2):132-142. doi:
10.1089/met.2013.0096
Palesch Y. Y.. Some Common Misperceptions About P Values. Stroke 2014; 45 (12):E244-E246.
Palesch Y. Y., Martin R. L., Speiser J. L., Hill M. D., Moy C. S., Barsan W. G., Ginsberg M. D.. Analysis of the 7-year alias parts 1 and 2 trials suggests adaptive designs may be considered for future trials to account for evolving medical management of stroke. International Journal of Stroke 2014; 9 ():217-217.
Palesch Y. Y., Yeatts S. D., Foster L. D., Khatri P., Tomsick T. A., Demchuk A. M., Hill M. D., Broderick J. P.. Endovascular treatment in the severe stroke cohort in the International Management of Stroke (IMS-III) trial may yield better clinical outcome over 12 months. International Journal of Stroke 2014; 9 ():17-17.
Pall H., Zacur G. M., Kramer R. E., Lirio R. A., Manfredi M., Shah M., Stephen T. C., Tucker N., Gibbons T. E., Sahn B., McOmber M., Friedlander J., Quiros J. A., Fishman D. S., Mamula P.. Bowel Preparation for Pediatric Colonoscopy: Report of the NASPGHAN Endoscopy and Procedures Committee. Journal of Pediatric Gastroenterology and Nutrition 2014; 59 (3):409-416.
Pandey J. P.. Genetic etiology of schizophrenia: Possible role of immunoglobulin γ genes. Psychiatric Genetics 2014; 24 (2):83-86. doi:
10.1097/YPG.0000000000000017
Pandey J. P.. Genetic Variants of Fcgamma (GM Allotypes) and the Fc-Mediated Effector Functions in HIV-1 Controllers. J Virol 2014; 88 (12):7117. doi:
10.1128/jvi.00726-14
Pandey J. P.. Comment on "Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway". J Immunol 2014; 192 (11):4941. doi:
10.4049/jimmunol.1400524
Pandey J. P.. Genetic etiology of schizophrenia: possible role of immunoglobulin gamma genes. Psychiatric Genetics 2014; 24 (2):83-6. doi:
10.1097/ypg.0000000000000017
Pandey J. P.. Immunoglobulin GM Genes, Cytomegalovirus Immunoevasion, and the Risk of Glioma, Neuroblastoma, and Breast Cancer. Front Oncol 2014; 4 ():236. doi:
10.3389/fonc.2014.00236
Pandey J. P., Kaur N., Costa S., Amorim J., Nabico R., Linhares P., Vaz R., Viana-Pereira M., Reis R. M.. Immunoglobulin genes implicated in glioma risk. OncoImmunology 2014; 3 (5):. doi:
10.4161/onci.28609
Pandey J. P., Kistner-Griffin E., Black L., Namboodiri A. M., Iwasaki M., Kasuga Y., Hamada G. S., Tsugane S.. IGKC and Fc gamma R genotypes and humoral immunity to HER2 in breast cancer. Immunobiology 2014; 219 (2):113-117.
Pandey J. P., Kistner-Griffin E., Namboodiri A. M., Iwasaki M., Kasuga Y., Hamada G. S., Tsugane S.. Higher levels of antibodies to the tumour-associated antigen cyclin B1 in cancer-free individuals than in patients with breast cancer. Clin. Exp. Immunol. 2014; 178 (1):75-78. doi:
10.1111/cei.12385
Pandey J. P., Kistner-Griffin E., Radwan F. F., Kaur N., Namboodiri A. M., Black L., Butler M. A., Carreon T., Ruder A. M.. Immunoglobulin Genes Influence the Magnitude of Humoral Immunity to Cytomegalovirus Glycoprotein B. Journal of Infectious Diseases 2014; 210 (11):1823-1826.
Pandey J. P., Namboodiri A. M.. Immunoglobulin GM and FcgammaRIIIa genotypes influence cytotoxicity of neuroblastoma cells. J Neuroimmunol 2014; 270 (1-2):95-7. doi:
10.1016/j.jneuroim.2014.03.003
Pandey J. P., Namboodiri A. M., Ohue Y., Oka M., Nakayama E.. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer. Clin. Exp. Immunol. 2014; 176 (1):78-83. doi:
10.1111/cei.12247
Pandey J. P., Namboodiri A. M., Ohue Y., Oka M., Nakayama E.. Genetic variants of immunoglobulin gamma and kappa chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer. Clin Exp Immunol 2014; 176 (1):78-83. doi:
10.1111/cei.12247
Pandey Janardan P.. Genetic etiology of schizophrenia: possible role of immunoglobulin γ genes. Psychiatr. Genet. (London, U. K.) 2014; 24 (2):83-86. doi:
10.1097/ypg.0000000000000017
Pandey Janardan P.. Genetic variants of Fcγ (GM allotypes) and the Fc-mediated effector functions in HIV-1 controllers. Journal of Virology 2014; 88 (12):7117, 2 pp. doi:
10.1128/jvi.00726-14
Pandey Janardan P., Namboodiri Aryan M.. Immunoglobulin GM and FcγRIIIa genotypes influence cytotoxicity of neuroblastoma cells. Journal of Neuroimmunology 2014; 270 (1-2):95-97. doi:
10.1016/j.jneuroim.2014.03.003
Paoletti Luca, Whelan Timothy P. M.. Lung transplantation for interstitial lung disease. Curr. Respir. Care Rep. 2014; 3 (3):96-102. doi:
10.1007/s13665-014-0083-3
Paolini P., Pick D., Lapira J., Sannino G., Pasqualini L., Ludka C., Sprague L. J., Zhang X., Bartolotta E. A., Vazquez-Hidalgo E., Barba D. T., Bazan C., Hardiman G.. Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes. Pharmacogenomics 2014; 15 (6):759-774. doi:
10.2217/pgs.14.39
Papanna R., Mann L., Tseng S., Stewart R., Kaur S., Swindle M., Argoti P., Garcia E., Tatevian N., Buhimschi I., Kyriakides T., Moise K.. Cryopreserved human amniotic membrane (hAM) with underwater adhesive coacervates (UAC) to seal and promote healing of iatrogenic fetal membrane defect site in a swine model. American Journal of Obstetrics and Gynecology 2014; 210 (1):S351-S351.
